Opinion statement
Purpose of review
Asthma is one of our society’s heaviest health burdens, which is estimated to be responsible for 250,000 deaths every year. Whenever severe asthma with fatal or near-fatal events is described, occupational asthma is not specifically mentioned, but its importance should not be underestimated.
Recent findings
Occupational asthma (OA) is the most prevalent work-related pulmonary disease. Therefore, it is a very important concern for health prevention and occupational health professionals. Although asthma treatments and earlier diagnosis have improved this condition’s control, severe exacerbations with unpredictable consequences still occur. Early diagnosis and allergen avoidance are the two main objectives in our approach to this disease. Obtaining a correct diagnosis and recognizing the responsible allergen is not an easy task to achieve, but it should be the clinician’s biggest concern. Severe exacerbations can be caused by many different triggers and their identification usually requires a well-trained expert in the field. Allergen avoidance should be the primary goal to avoid fatal or near-fatal asthma events, but good asthma control also is necessary to decrease OA future risk. The asthmagens involved in severe reactions are heterogeneous, making their identification difficult, but necessary. As these agents are used in very different industries and can be ubiquitous, OA should be considered in every patient with work-related asthma exacerbations or symptoms.
Summary
Severe events have been described with many types of agents and allergenic sources; therefore, every patient should be treated to obtain a good illness control, regardless of the responsible allergenic source.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
World Health Organization. WHO Projections of mortality and burden of the disease 2004–2030. Available at: http://www.who.int/healthinfo/global/burden_disease/Dth6_2030.xls.
Carvajal-Ureña I, García-marcos L, Busquets-Monge R, Suárez-Varela MM, De Andoni NG. Variaciones geográficas en la prevalencia de síntomas de asma en los niños y adolescentes españoles. Int StudAsthma Allergies Child (ISAAC). 2005;41:659–66.
The Global Asthma Report 2014 [Internet]. Available at: http://www.globalasthmareport.org/burden/burden.php.
World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach [Internet]. Available at: http://apps.who.int/iris/bitstream/10665/43776/1/9789241563468_eng.pdf.
Jenkins MA, Rubinfield ARR, Robertson CS, Bowes G. Accuracy of asthma deaths statistics in Australia. Aust J Public Health. 1992;16(4):427–9.
Wright SC, Evans AE, Sinnamon DG, Mac Mahon J. Asthma mortality and death certification in Northern Ireland. Thorax. 1994;49(2):141–3. https://doi.org/10.1136/thx.49.2.141.
Reid DWEC, Hendrick VJ, Aitken TC, Berrill WT, Stenton SC, Hendrick DJ. Age-dependent inaccuracy of asthma death certification in Northern England, 1991–1992. Eur Respir J. 1998;12(5):1079–83. https://doi.org/10.1183/09031936.98.12051079.
Richards GN, Kolbe J, Fenwick J, Rea HH. Demographic characteristics of patients with severe life threatening asthma: comparision with asthma deaths. Thorax. 1993;48(11):1105–9. https://doi.org/10.1136/thx.48.11.1105.
• Serrano-Pariente J, Rodrigo G, Fiz JA, Crespo A, Plaza V. Identification and characterization of near fatal asthma phenotypes by cluster analysis. Allergy. 2015;70:1139–47. A cluster analysis is performed on the NFA events over 2 years on 179 Spanish hospitals. Three different NFA phenotypes were described. This phenotype identification can lead to a reduction on the NFA events on the future.
Campbell DA, McLennan G, Coates JR, Frith PA, Gluyas PA, Latimer KM, et al. A comparison of asthma deaths and near fatal asthma attacks in South Australia. Eur Respir J. 1994;7(3):490–7. https://doi.org/10.1183/09031936.94.07030490.
Jeebhay M, Quirce S. Occupational asthma in the developing and industrialised world: a review. Int J Tuber Lung Dis. 2007;11:122–33.
Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008;134(3):1S–41S. https://doi.org/10.1378/chest.08-0201.
• Malo JL, Vandenplas O. Definitions and classification of work-related asthma. Immunol Allergy Clin North Am. 2011;31:645–62. WRA is described and classified into its different phenotypes, describing their features and analyzing existing data and its controversies.
Vandenplas O, Malo JL. Definitions and types of work-related asthma: a nosological approach. Eur Respir J. 2003;21(4):706–12. https://doi.org/10.1183/09031936.03.00113303.
Shofer S, Haus BM, Kuschner WG. Quality of occupational history assessments in working age adults with newly diagnosed asthma. Chest. 2006;130(2):455–62. https://doi.org/10.1378/chest.130.2.455.
Breton CV, Zhan Z, Hunt PR, Pechter E, Davis L. Characteristics of work related asthma: results from a population based survey. Occup Environ Med. 2006;63(6):411–5. https://doi.org/10.1136/oem.2005.025064.
• Johnson AR, Dimich-Ward HD, Manfreda J, Becklake J, Ernst P, et al. Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med. 2000;162:2058–62. Population of six Canadian communities was studied determining prevalence, population attributable risk, and clinical characteristics of occupational asthma.
Tarlo SM, Leung K, Broder I, Silverman F, Holness DL. Asthmatic subjects symptomatically worse at work: prevalence and characterization among a general asthma clinic population. Chest. 2000;118(5):1309–14. https://doi.org/10.1378/chest.118.5.1309.
Fishwick D. Work aggravated asthma; a review of the recent evidence. Br Med Bull. 2014;110(1):77–88. https://doi.org/10.1093/bmb/ldu004.
GINA [internet]. Available at: http://ginasthma.org.
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Resp J. 2014;43(2):343–73. https://doi.org/10.1183/09031936.00202013.
•• Tarlo SM, Lemière C. Occupational asthma. N Engl J Med. 2014;370:640–9. Existing data on OA is critically reviewed in order to define its clinical features, diagnostic approach, and specific management.
Vandenplas O, Dressel H, Wilken D, Jamart J, Heecerik D, et al. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J. 2011;38(4):804–11. https://doi.org/10.1183/09031936.00177510.
Meca O, Cruz MJ, Sánchez-Ortiz M, González-Barcala FJ, Ojanguren I, Munoz X. Do low molecular weight agents cause more severe asthma than high molecular weight agents? Plos One. 2016;11(6):e0156141. https://doi.org/10.1371/journal.pone.0156141.
Le Moual N, Siroux V, Pin I, Kauffmann F, Kennedy SM, Epidemiological Study on the Genetics and Environment of Asthma. Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med. 2005;172(4):440–5. https://doi.org/10.1164/rccm.200501-111OC.
The European Community Respiratory Health Survey (ECRHS). [Internet] Available at: http://www.ecrhs.org/.
Malo JL. Asthma may be more severe if it is work-related. Am J Respir Crit Care Med. 2005;172(4):406–7. https://doi.org/10.1164/rccm.2506006.
Simpson JL, Guest M, Boggess MM, Gibson PG. Occupational exposures, smoking and airway inflammation in refractory asthma. BMC Pulm Med. 2014;14(1):207. https://doi.org/10.1186/1471-2466-14-207.
Coman I, Lemière C. Fractional exhaled nitric oxide (FeNO) in the screening and diagnosis work-up of occupational asthma. Curr Treat Options Allergy. 2017;4(2):145–59. https://doi.org/10.1007/s40521-017-0122-8.
Moscato G, Pala G, Folletti I, Siracusa A, Quirce S. Occupational rhinitis affects occupational asthma severity. J Occup Health. 2016;58:310–3.
White GE, Mazurek JM, Storey E. Employed adults with asthma who have frequent workplace exposures. J Asthma. 2015;52(1):46–51. https://doi.org/10.3109/02770903.2014.944984.
Henneberger PK, Mirabelli MC, Kogevinas M, Antó JM, Plana E, et al. The occupational contribution to severe exacerbation of asthma. Eur Respir J. 2010;36(4):743–50. https://doi.org/10.1183/09031936.00135109.
Henneberger PK, Liang X, Lillienberg L, Dahlman-Höglund A, Torén K, Andersson E. Occupational exposures associated with severe exacerbation of asthma. Int J Tuberc Lung Dis. 2015;19(2):244–50. https://doi.org/10.5588/ijtld.14.0132.
Lemirère C, Boulet LP, Chaboillez S, Forget A, Chiry S, et al. Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol. 2013;131(3):704–10. https://doi.org/10.1016/j.jaci.2012.08.024.
Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005;62(5):290–9. https://doi.org/10.1136/oem.2004.016287.
Esteban-Gorgojo I, Rial MJ, Sastre J. Infrequent treatments for occupational asthma: immunotherapy and biological treatments. Curr Treat Options Allergy. 2017;4(2):118–28. https://doi.org/10.1007/s40521-017-0125-5.
Hawley B, Cummings KJ, Mohammed M, Dimmock AE, Bascom R. Allergic sinusitis and severe asthma caused by occupational exposure to locust bean gum: case report. Am J Ind Med. 2017;60(7):658–63. https://doi.org/10.1002/ajim.22725.
Groetschel HWE. Death of a printer from bronchial asthma after working with wet sprays. Arch Gewerbepath Gewerbehyg. 1958;16:375–86.
Murray JF, Fink A. Toxicity from certain brominated alkylating agents. Arch Environ Health. 1962;5(1):5–11. https://doi.org/10.1080/00039896.1962.10663234.
Flindt MLH. Respiratory hazards from papain. Lancet. 1978;311(8061):430–2. https://doi.org/10.1016/S0140-6736(78)91216-3.
Fabbri L, Daniell D, Cresciol S, et al. Fatal asthma in a subject sensitized to toluene diisocyanate-4. Am Rev Respir Dis. 1988;137(6):1494–8. https://doi.org/10.1164/ajrccm/137.6.1494.
Carino M, Aliani M, Licitra C, Sarno N, Ioli F. Death due to asthma at workplace in a diphenylmethane diisocyanate-sensitized subject. Respiration. 1997;64(1):111–3. https://doi.org/10.1159/000196653.
Chester DA, Hanna EA, Pickelman BG, Rosenman KD. Asthma death after spraying polyurethane truck bedliner. Am J Ind Med. 2005;48(1):78–84. https://doi.org/10.1002/ajim.20183.
•• NIOSH. 1996. Preventing asthma and death from diisocyanate exposure. Atlanta, GA, Centers for Disease Control and Prevention. Seven cases of severe respiratory disease and deaths due to diisociaate exposure, showing the importance of health prevention measurements to offending allergens.
Ehrlich RI. Fatal asthma in a baker: a case report. Am J Ind Med. 1994;26(6):799–802. https://doi.org/10.1002/ajim.4700260608.
•• Ortega HG, Kreiss K, Schill DP, Weissman DN. Fatal asthma from powdering shark cartilage and review of fatal occupational asthma literature. Am J Ind Med. 2002;42:50–4. A FA event due to shark cartilage is reported and described placing it among other FA events and analyzing the characteristics and risk factors for these events to happen.
Michigan Fatality Assessment & Control Evaluation, M. 2005. Fatal asthma while cleaning bulk milk tank. East Lansing, MI: Michigan State University, Department of Medicine, Occupational and Environmental Medicine, HA#6; 2005:1
Fukushima C, Shimoda T, Matsuse H, et al. Fatal asthma with rhabdomyolysis induced by hair dye. Acta Med Nagasaki. 1998;43:58–62.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ignacio Esteban-Gorgojo declares that he has no conflict of interest. Isabel Coman declares that she has no conflict of interest. Manuel Jorge Rial declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Occupational Allergy
Rights and permissions
About this article
Cite this article
Esteban-Gorgojo, I., Coman, I. & Rial, M.J. Occupational Asthma, Not a Trivial Disorder and a Source of Fatal and Near-Fatal Events. Curr Treat Options Allergy 5, 1–10 (2018). https://doi.org/10.1007/s40521-018-0161-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40521-018-0161-9